ACADEMIC RADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2025-07-21 aifeige82 来自上海

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经影像
经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。

2 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2025-07-16 老唐1982 来自重庆

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：fMRI;新生儿HIE
经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊

3 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2025-06-11 ms5000001648072301 来自天津

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：乳腺肿瘤
经验分享：投稿第二天就变成Decision in Process，怕是要被拒了

8 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2024-10-09 ms8000000121798389 来自浙江省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：影像组学;肿瘤
经验分享：2024.07.16 投稿
2024.07.17 格式问题重新提交
2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人）
2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题
2024.08.05 返回修改意见，并提交修改稿
2024.08.14 接收accepted for publication
从提交到接受不到一个月，神速！

63 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2022-11-11 今天审稿人爸爸心情好了吗

审稿速度:1.0 | 投稿命中率:50.0
经验分享：10.13 submit
11.2 major
11.10 re-submit

230 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2024-04-15 ms8000000162197703 来自重庆

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：MRI;妇科影像
经验分享：3.17 submission
3.19 with editor
3.21 under review
4.1 Major revision
4.10 Revision Submitted
4.12 with editor
4.12 Minor revision
4.14 Revision Submitted
4.14 Accept
从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！

132 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2022-10-26 12114defm22(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
经验分享：别选OA，发在了增刊上。

237 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2025-03-27 ms4000000630574235 来自江苏省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：杂志很好

21 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2020-02-14 Hanwin

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了

373 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2274207, encodeId=a8d122e4207be, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经影像 经验分享：效率奇高的期刊，点赞。6.17投稿，7.7号返修，7.17上传返修稿，7.20接受。感觉主编意见占主导。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca111422743, createdName=aifeige82, createdTime=Mon Jul 21 10:11:43 CST 2025, time=2025-07-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2273571, encodeId=89a322e357195, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：fMRI;新生儿HIE 经验分享：投稿26天，大修，6天后修回，2天后aceppt,投稿到接收共34天，优秀的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e18d1959992, createdName=老唐1982, createdTime=Wed Jul 16 09:27:16 CST 2025, time=2025-07-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2268851, encodeId=a3cb22688511a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺肿瘤 经验分享：投稿第二天就变成Decision in Process，怕是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38819694626, createdName=ms5000001648072301, createdTime=Wed Jun 11 09:43:30 CST 2025, time=2025-06-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230075, encodeId=36ed22300e5fb, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：影像组学;肿瘤 经验分享：2024.07.16 投稿 2024.07.17 格式问题重新提交 2024.07.18 格式问题解决，提示请注意追踪文章状态（是不是可以理解为开始邀请审稿人） 2024.08.04 收到修稿通知，审稿人一14个问题，审稿人二，8个问题 2024.08.05 返回修改意见，并提交修改稿 2024.08.14 接收accepted for publication 从提交到接受不到一个月，神速！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Wed Oct 09 23:33:48 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099969, encodeId=e063209996928, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：10.13 submit 11.2 major 11.10 re-submit, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57cf5432548, createdName=今天审稿人爸爸心情好了吗, createdTime=Fri Nov 11 20:00:03 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257954, encodeId=74d8225e95404, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18525441, createdName=ms4000000630574235, createdTime=Thu Mar 27 12:52:28 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省)]

2024-04-09 ms7000001717279760 来自安徽省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：影像组学;宫颈癌;IVIM-DWI
经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。

120 3 举报

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务